Topiramate
Product manufactured by Denton Pharma, Inc. Dba Northwind Pharmaceuticals
Indications and Purposes
| 1 Indications And Usage Topiramate Is Indicated For: • Epilepsy: Initial Monotherapy In Patients ≥2 Years Of Age With Partial Onset Or Primary Generalized Tonic-Clonic Seizures (1.1); Adjunctive Therapy For Adults And Pediatric Patients (2 To 16 Years Of Age) With Partial Onset Seizures Or Primary Generalized Tonic-Clonic Seizures, And For Patients ≥2 Years Of Age With Seizures Associated With Lennox-Gastaut Syndrome (1.2) • Prophylaxis Of Migraine In Patients 12 Years Of Age And Older (1.3) 1.1 Monotherapy Epilepsy Topiramate Tablets Are Indicated As Initial Monotherapy In Patients 2 Years Of Age And Older With Partial Onset Or Primary Generalized Tonic-Clonic Seizures. 1.2 Adjunctive Therapy Epilepsy Topiramate Tablets Are Indicated As Adjunctive Therapy For Adults And Pediatric Patients 2 To 16 Years Of Age With Partial Onset Seizures Or Primary Generalized Tonic-Clonic Seizures, And In Patients 2 Years Of Age And Older With Seizures Associated With Lennox-Gastaut Syndrome. 1.3 Migraine Topiramate Tablets Are Indicated For Patients 12 Years Of Age And Older For The Prophylaxis Of Migraine Headache. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Topiramate |
|
ZINC95616603 |